Protalix BioTherapeutics, Inc. (PLX) vs Whitehawk Therapeutics, Inc. (WHWK)

Protalix BioTherapeutics, Inc. and Whitehawk Therapeutics, Inc. are both Biotechnology companies. Protalix BioTherapeutics, Inc. and Whitehawk Therapeutics, Inc. are of similar size ($221.6M and $220.1M). Whitehawk Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Protalix BioTherapeutics, Inc. trades at 11.3×. Protalix BioTherapeutics, Inc. grew revenue faster over the last twelve months: 30.1% against 16.5%. Protalix BioTherapeutics, Inc. has the higher net margin (23.5% vs 0.00%) and the higher return on invested capital (48.5% vs 0.00%). Across the 17 metrics below, Protalix BioTherapeutics, Inc. leads on 12 and Whitehawk Therapeutics, Inc. on 5.